Home » Topics » Regulatory

Regulatory
RSS

FDA approval for subcutaneous immunoglobulin treatment Vivaglobin

Jan. 11, 2006

Climara Pro approved for prevention of postmenopausal osteoporosis

Jan. 9, 2006

FDA approval for Vaprisol in euvolemic hyponatremia

Jan. 2, 2006

Femara receives new U.S. approval

Dec. 30, 2005

Revlimid receives FDA approval

Dec. 29, 2005

Orencia approved for rheumatoid arthritis

Dec. 28, 2005

Nexavar receives FDA approval for advanced renal cell carcinoma

Dec. 22, 2005

Depakote ER receives new approval in bipolar disorder

Dec. 19, 2005

Iplex approved for severe primary IGF-1 deficiency

Dec. 15, 2005

Korean approval for udenafil in erectile dysfunction

Dec. 1, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...